Pathway RX
Research - , ,
Pathway RX Employees
Pathway RX Details
Pathway Research (Pathway Rx) is a research company dedicated to studying the effectiveness of cannabis compounds and developing custom cannabis therapies aimed at treating specific ailments and diseases. Pathway Rx Founder and CEO, Dr. Igor Kovalchuk is an award-winning expert in genetics and molecular biology and is one of the first researchers to be granted a Health Canada cannabis research license. Pathway Rx operates in partnership with the University of Lethbridge and other companies including Swysh Inc., an oral health product developer, InPlanta Biotechnology, a licensed cannabis nursery that generated over 1,000 hybrids, and Sundial Growers ("Nasdaq: SNDL"), an Alberta-based licensed cannabis producer.
Pathway RX Technologies
Email Providers
Outlook
Load Balancers
Varnish
Fonts
Google Font API
Other
Mobile Friendly